Heteroaryl-ureas and their use as glucokinase activators

Details for Australian Patent Application No. 2005203930 (hide)

Owner Novo Nordisk A/S

Inventors Murray, Anthony; Polisetti, Dharma Rao; Cooper, Jeremy T.; Vedso, Per; Subramanian, Govindan; Kristiansen, Marit; Santhosh, Kalpathy Chidambareswaran; Lundbeck, Jane Marie; Jeppesen, Lone; Andrews, Robert Carl; Christen, Daniel P.; Ankersen, Michael; Lau, Jesper; Valcarce-Lopez, Maria Carmen

Agent Shelston IP

Pub. Number AU-B-2005203930

PCT Pub. Number WO2005/066145

Priority PA 2004 00013 06.01.04 DK; PA 2004 01897 07.12.04 DK; PA 2004 01272 23.08.04 DK

Filing date 6 January 2005

Wipo publication date 21 July 2005

Acceptance publication date 14 July 2011

International Classifications

C07D 277/48 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/4168 (2006.01)

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 271/08 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/60 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/08 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 285/135 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 285/12 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066145 Priority application(s): WO2005/066145

14 July 2011 Application Accepted

  Published as AU-B-2005203930

3 November 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Oct 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

23 February 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Oct 2011

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203933-A building or window element and a method of producing a building

2005203925-Glucagon-Like Peptide-1 analogs with long duration of action